Med III B S.L.P. is a private equity fund based in Lyon, France. According to its most recent Form D, filed Aug 13, 2021, it has sold $25,231,855 of interests to 12 investors since its first sale in Aug 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Med III GP; ArchiMed SAS.
- Total raised
- $25,231,855Cumulative sales reported on Form D
- Investors
- 12
- First sale
- Aug 2, 2021
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Med III GP; ArchiMed SAS
- Latest Form D
- Aug 13, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Med III B S.L.P.
What is the minimum investment for Med III B S.L.P.?
Med III B S.L.P.'s latest Form D, filed Aug 13, 2021, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Med III B S.L.P.?
Med III B S.L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Med III B S.L.P. raised?
Med III B S.L.P. reports $25,231,855 sold from 12 investors on its Form D filed Aug 13, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is Med III B S.L.P. based?
Med III B S.L.P. is based in Lyon, France.
When did Med III B S.L.P. launch?
Med III B S.L.P. reports its first sale in Aug 2021.
Size compared with every private equity fund
Raised more than 64% of the 22 private equity funds based in France, and more than 55% of all 8,931 that report sales.